Return On Equity ratio Analysis of Sun Pharmaceutical Industries Ltd. - Deep Dive
Latest FY ROE
Period Ending - Mar-25
Good ROE
15.18
Period Ending - Mar-24
Good ROE
15.04
Growth
0.940 %
Trailing Twelve Months ROE
Period Ending - Mar-25
Good ROE
16.18
Most recent Quarter ROE
Period Ending - Mar-25
Indecisive ROE
2.98
ROE Analysis of Sun Pharmaceutical Industries Ltd.
ROE Ratio of Sun Pharmaceutical Industries Ltd. with value of 16.18 means its generates profits efficiently by using its Shareholders Fund. |
ROE Ratio of SUNPHARMA has grown by 0.940 % Compared to previous Financial Year. |
ROE Ratio with value of 15.29 was highest in Year Mar-23 in last Five Years. |
ROE Ratio with value of 6.25 was lowest in Year Mar-21 in last Five Years. |
Latest ROE Ratio with value of 15.18 is Greater than Average ROE of 11.72 in last five years. |
Other ROE Related Info of SUNPHARMA that may interest you.
Sun Pharmaceutical Industries Ltd. Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
SUNPHARMA | 1694.40 | 1679.20 | 0.905 % | Drugs & Pharma |
Defination of Return On Equity
The Return on Equity (ROE) is a profitability metric that measures a company's ability to generate profits using its shareholder's fund. ROE is calculated by dividing Net Income by Shareholders' Fund. more ..
ROE Related Ratios
ReturnOnAsset | NetProfitMargin |
Tsr Profitability Index
No Significant Profitability | Screener |
FY - Historical Return On Equity of Sun Pharmaceutical Industries Ltd.
Period | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 |
---|---|---|---|---|---|---|---|
ROE | 15.18 | 15.04 | 15.29 | 6.82 | 6.25 | 8.32 | 6.44 |
Change | 0.940 % | -1.62 % | 124.28 % | 9.07 % | -24.86 % | 29.22 % | 13.46 % |
Price | 1734.70 | 1620.55 | 983.10 | 914.75 | 597.80 | 352.30 | 478.85 |
Price Change | 7.04 % | 64.84 % | 7.47 % | 53.02 % | 69.68 % | -26.43 % | -3.28 % |